Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$13.09 - $14.98 $1.86 Million - $2.13 Million
-141,900 Reduced 27.13%
381,200 $5.33 Million
Q3 2023

Nov 14, 2023

BUY
$12.64 - $14.99 $6.61 Million - $7.84 Million
523,100 New
523,100 $7.73 Million
Q1 2020

May 15, 2020

SELL
$2.27 - $6.2 $905,920 - $2.47 Million
-399,084 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$3.46 - $6.93 $2.04 Million - $4.09 Million
-589,841 Reduced 59.64%
399,084 $2.28 Million
Q3 2019

Nov 15, 2019

BUY
$2.69 - $4.85 $1.17 Million - $2.1 Million
433,925 Added 78.18%
988,925 $3.54 Million
Q2 2019

Aug 14, 2019

BUY
$3.65 - $7.89 $2.03 Million - $4.38 Million
555,000 New
555,000 $2.21 Million
Q4 2018

Feb 14, 2019

SELL
$8.14 - $13.28 $1.2 Million - $1.96 Million
-147,934 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$11.85 - $16.0 $15.5 Million - $20.9 Million
-1,307,100 Reduced 89.83%
147,934 $1.83 Million
Q2 2018

Aug 14, 2018

SELL
$15.15 - $20.75 $54.7 Million - $74.9 Million
-3,608,900 Reduced 71.27%
1,455,034 $22.2 Million
Q1 2018

May 15, 2018

BUY
$14.65 - $19.9 $18.4 Million - $25 Million
1,255,792 Added 32.98%
5,063,934 $101 Million
Q4 2017

Feb 14, 2018

BUY
$17.3 - $24.08 $46.7 Million - $65 Million
2,697,514 Added 242.88%
3,808,142 $71.2 Million
Q3 2017

Nov 14, 2017

BUY
$15.2 - $21.5 $16.9 Million - $23.9 Million
1,110,628
1,110,628 $23.9 Million

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.44B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.